GB0313915D0 - Compounds - Google Patents

Compounds

Info

Publication number: GB0313915D0
Authority: GB; United Kingdom
Prior art keywords: compounds
Prior art date: 2003-06-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0313915.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-16

Filing date

2003-06-16

Publication date

2003-07-23

2003-06-16 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2003-06-16 Priority to GBGB0313915.1A priority Critical patent/GB0313915D0/en

2003-07-23 Publication of GB0313915D0 publication Critical patent/GB0313915D0/en

2004-06-14 Priority to PCT/EP2004/006427 priority patent/WO2004111036A1/en

2004-06-14 Priority to JP2006515936A priority patent/JP2006527722A/en

2004-06-14 Priority to EP04739898A priority patent/EP1656367A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB0313915.1A 2003-06-16 2003-06-16 Compounds Ceased GB0313915D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB0313915.1A GB0313915D0 (en)	2003-06-16	2003-06-16	Compounds
PCT/EP2004/006427 WO2004111036A1 (en)	2003-06-16	2004-06-14	4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor
JP2006515936A JP2006527722A (en)	2003-06-16	2004-06-14	4- (Heterocycle-fused phenyl) -3- (phenyl or pyrid-2-yl) pyrazole as an inhibitor of the ALK-5 receptor
EP04739898A EP1656367A1 (en)	2003-06-16	2004-06-14	4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0313915.1A GB0313915D0 (en)	2003-06-16	2003-06-16	Compounds

Publications (1)

Publication Number	Publication Date
GB0313915D0 true GB0313915D0 (en)	2003-07-23

Family

ID=27636631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0313915.1A Ceased GB0313915D0 (en)	2003-06-16	2003-06-16	Compounds

Country Status (4)

Country	Link
EP (1)	EP1656367A1 (en)
JP (1)	JP2006527722A (en)
GB (1)	GB0313915D0 (en)
WO (1)	WO2004111036A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR039241A1 (en)	2002-04-04	2005-02-16	Biogen Inc	HETEROARILOS TRISUSTITUIDOS AND METHODS FOR ITS PRODUCTION AND USE OF THE SAME
CL2004000234A1 (en) *	2003-02-12	2005-04-15	Biogen Idec Inc	DERIVATIVE COMPOUNDS 3- (PIRIDIN-2-IL) -4-HETEROARIL-PIRAZOL SUBSTITUTED, ANTAGONISTS OF AIK5 AND / OR AIK4; PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND IN THE TREATMENT OF FIBROTIC DISORDERS AS SCLERODERMIA, LUPUS NEFRITICO, CICATRIZACION DE HERID
TW200639163A (en) *	2005-02-04	2006-11-16	Genentech Inc	RAF inhibitor compounds and methods
US20100056505A1 (en) *	2005-11-21	2010-03-04	Biogen Idec Ma Inc.	Substituted Pyrazalones
BRPI0709267A2 (en) *	2006-03-28	2011-06-28	Wyeth Corp	gdf-9 / bmp-15 modulators for treating bone disorders
ES2393932T3 (en)	2006-07-14	2013-01-02	Novartis Ag	Pyrimidine derivatives as ALK-5 inhibitors
EP1878733A1 (en) *	2006-07-14	2008-01-16	Novartis AG	Pyrimidine derivatives as ALK-5 inhibitors
TW201107303A (en) *	2009-05-27	2011-03-01	Sanofi Aventis	Process for the production of benzofurans
JO3336B1 (en) *	2014-10-07	2019-03-13	Lilly Co Eli	Aminopyridyloxypyrazole compounds
WO2018019106A1 (en)	2016-07-29	2018-02-01	上海璎黎药业有限公司	Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof
BR112021011224A2 (en)	2018-12-11	2021-08-24	Theravance Biopharma R&D Ip, Llc	alk5 inhibitors
JP2023502662A (en) *	2019-11-22	2023-01-25	セラヴァンスバイオファーマアール＆ディーアイピー，エルエルシー	Substituted 1,5-naphthyridines or quinolines as ALK5 inhibitors
EP4173675A1 (en) *	2021-10-26	2023-05-03	Perha Pharmaceuticals	Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3734180B2 (en) *	1994-12-28	2006-01-11	エーザイ株式会社	New pyrazole derivatives
GB0027987D0 (en) *	2000-11-16	2001-01-03	Smithkline Beecham Plc	Compounds
GB0102672D0 (en) *	2001-02-02	2001-03-21	Glaxo Group Ltd	Compounds
MXPA03008142A (en) *	2001-03-09	2003-12-12	Pfizer Prod Inc	Benzimidazole anti-inflammatory compounds.
ATE374753T1 (en) *	2001-12-21	2007-10-15	Vernalis Cambridge Ltd	3-(2,4)DIHYDROXYPHENYL-4-PHENYLPYRAZOLES AND THEIR MEDICAL USE
DE60330362D1 (en) *	2002-09-18	2010-01-14	Pfizer Prod Inc	NEW PYRAZOL COMPOUNDS AS AN INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF)
CL2004000234A1 (en) *	2003-02-12	2005-04-15	Biogen Idec Inc	DERIVATIVE COMPOUNDS 3- (PIRIDIN-2-IL) -4-HETEROARIL-PIRAZOL SUBSTITUTED, ANTAGONISTS OF AIK5 AND / OR AIK4; PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND IN THE TREATMENT OF FIBROTIC DISORDERS AS SCLERODERMIA, LUPUS NEFRITICO, CICATRIZACION DE HERID

2003
- 2003-06-16 GB GBGB0313915.1A patent/GB0313915D0/en not_active Ceased
2004
- 2004-06-14 EP EP04739898A patent/EP1656367A1/en not_active Withdrawn
- 2004-06-14 WO PCT/EP2004/006427 patent/WO2004111036A1/en not_active Ceased
- 2004-06-14 JP JP2006515936A patent/JP2006527722A/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1656367A1 (en)	2006-05-17
JP2006527722A (en)	2006-12-07
WO2004111036A1 (en)	2004-12-23

Publication	Publication Date	Title
GB0316915D0 (en)	2003-08-20	Compounds
GB0309781D0 (en)	2003-06-04	Compounds
GB0315950D0 (en)	2003-08-13	Compounds
GB0305559D0 (en)	2003-04-16	Compounds
GB0317268D0 (en)	2003-08-27	Compounds
GB0314476D0 (en)	2003-07-23	Compounds
GB0314479D0 (en)	2003-07-23	Compounds
GB0304665D0 (en)	2003-04-02	Compounds
GB0314478D0 (en)	2003-07-23	Compounds
EP1689403A4 (en)	2007-09-05	Heteroaryl-hydrazone compounds
GB0317498D0 (en)	2003-08-27	Compounds
GB0305553D0 (en)	2003-04-16	Compounds
GB0313915D0 (en)	2003-07-23	Compounds
GB0306329D0 (en)	2003-04-23	Compounds
GB0313914D0 (en)	2003-07-23	Compounds
EP1682514A4 (en)	2008-07-16	11- o-methylgeldanamycin compounds
GB0302512D0 (en)	2003-03-05	Compounds
GB0304494D0 (en)	2003-04-02	Compounds
GB0317269D0 (en)	2003-08-27	Compounds
GB0310851D0 (en)	2003-06-18	Compounds
GB0312356D0 (en)	2003-07-02	Compounds
GB0308017D0 (en)	2003-05-14	Compounds
GB0308105D0 (en)	2003-05-14	Compounds
GB0309326D0 (en)	2003-06-04	Compounds
GB0304493D0 (en)	2003-04-02	Compounds

Legal Events

Date	Code	Title	Description
2004-09-15	AT	Applications terminated before publication under section 16(1)